What is the lowest limit of quantification for mouse IL-6 ELISA? Is it feasible to measure it together with TNF-α?

When selecting suppliers, don't just ask whether they have ELISA; focus on small-volume multiplex or high-sensitivity versions. R&D's high-sensitivity ELISA, BioLegend's LegendPlex, Thermo's ProcartaPlex, and MSD's U-PLEX all offer mouse IL-6/TNF-α panels, but sample types and volume requirements differ. Ask directly: Is there validation data for BALF? What is the minimum volume per well in microliters? Are the plates breakable? Are the standards lyophilized? Can delivery be within two weeks? Some distributors can help with small-sample pilot tests or provide trial aliquots. Measuring both targets simultaneously with multiplex assays also reduces inter-plate variability. Ultimately, use spike recovery and linear dilution to judge performance; BALF matrix has lower protein content and relatively less interference than serum, but validation still cannot be skipped.

If you insist on running the ELISAs separately, first check the manual for the actual minimum sample volume required for each analyte. For example, some kits require 50 μL per well, and duplicates require 100 μL, so 100 μL is just enough for one analyte and cannot be split in half. If the kit supports 25 μL/well, duplicates require 50 μL, and two analytes require exactly 100 μL, but the CV risk increases, so you can run single wells plus one quality control. It is more advisable to pool several samples and test the recovery and CV at 25/50 μL loading volumes. If the sample is precious, prioritize IL-6, because if the TNF-α sample volume is insufficient, it is also convenient to send it to a multiplex platform for supplementary testing. When processing the data, note the actual sample volume loaded per well.

For each 100 μL BALF sample, two analytes need to be measured, and splitting the sample for conventional ELISA is indeed tight. If the platform allows, my first recommendation is to use multiplex assays: Luminex or MSD mouse IL-6/TNF-α multiplex kits, which can measure both analytes simultaneously in a single well, often requiring only 25-50 μL of sample, leaving the remainder for backup. Luminex requires a magnetic bead reader or flow cytometer, and MSD requires a dedicated plate reader. If you don't have the equipment, it's more convenient to find a third-party or core facility for testing. When choosing, ask clearly: whether the kit has been validated for BALF, the minimum sample volume, whether the standards are fresh, and the lead time. Multiplex assays have high upfront costs, but for small-volume samples, they are indeed more friendly than two separate ELISAs.

A standard ELISA with a nominal sensitivity of 7.8 pg/mL is usually inadequate for baseline IL-6 in BALF, while a high-sensitivity version with a nominal sensitivity of 2 pg/mL performs better, but the nominal detection limit does not equal the lower limit of quantification (LLOQ) in actual samples. It is recommended to first use pooled samples from several representative BALF specimens for serial dilution and spike-and-recovery experiments to determine your own LLOQ. If the concentration is indeed low, either use the high-sensitivity version or concentrate the BALF 2-5 fold using ultrafiltration devices. Concentration carries risks: interferents are concentrated along with the analyte, and protein loss must also be accepted. TNF-alpha is generally easier to measure than IL-6 in BALF after induction, so prioritize sample volume for IL-6. Do not run a single sample directly on the instrument; first perform a pilot experiment with pooled samples before deciding on the protocol.